Olema Pharmaceuticals, Inc.
OLMA
20 insider filings · Latest: Jun 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | Dec 10 7:38 PM | Harmon Cyrus | Proposed Sale | 8,256 | $9.37 | $77.4K | — | View → |
| Dec 10, 2024 | Dec 10 7:21 PM | Kovacs Shane William Charles | Proposed Sale | 16,803 | $9.37 | $157.4K | — | View → |
| Dec 10, 2024 | Dec 10 7:14 PM | Zojwalla Naseem | Proposed Sale | 13,283 | $9.37 | $124.5K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 23 9:52 PM | P/Il L Bvf PartnersDirector, Other | Grant/Award | 29,500 | $9.51 | 29,500(I) | View → |
| Jun 18, 2026 | Jun 23 9:30 PM | Cyrus HarmonDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:29 PM | Cynthia M ButittaDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:28 PM | Scott J. GarlandDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:27 PM | Gorjan HrustanovicDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:26 PM | Ian T ClarkDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:25 PM | Yi LarsonDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:24 PM | Sandra HorningDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:23 PM | Prakash RamanDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:22 PM | Andrew RappaportDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:21 PM | Graham G. WalmsleyDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Apr 28, 2026 | Apr 29 11:53 PM | Prakash RamanDirector | Grant/Award | 27,061 | $14.59 | 24,150(D) | View → |
| Mar 4, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Option Exercise | 25,000 | $4.37 | 410,000(D) | View → |
| Mar 3, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Option Exercise | 15,000 | $4.37 | 435,000(D) | View → |
| Feb 2, 2026 | Feb 18 2:35 AM | Sasha Lu AustinVP of Finance and Controller | Grant/Award | 29,250 | $25.65 | 29,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | Naseem ZojwallaCHIEF MEDICAL OFFICER | Grant/Award | 356,250 | $25.65 | 106,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | David C. MylesCH. DISCOV. & NON-CLIN DEV OFF | Grant/Award | 356,250 | $25.65 | 106,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Grant/Award | 276,250 | $25.65 | 56,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | Sean BohenDirector, PRESIDENT AND CEO | Grant/Award | 1,125,000 | $25.65 | 275,000(D) | View → |